Status:
COMPLETED
Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborating Sponsors:
University of Basel
Charite University, Berlin, Germany
Conditions:
Stroke
Transient Ischemic Attack
Eligibility:
All Genders
Brief Summary
Prospective observational multicenter study to evaluate copeptin as a prognostic marker in patients with an acute cerebrovascular event. It includes four groups of patients, mainly depending on type o...
Detailed Description
Background The investigators in the Prolyse in Acute Cerebral Thromboembolism (PROACT) II study found that intra-arterial thrombolysis (IAT) with prourokinase within 6 hours after onset of symptoms w...
Eligibility Criteria
Inclusion
- All consecutive patients who are admitted to the emergency department with a clinical diagnosis of cerebrovascular event (TIA, stroke) within 24 hours of symptom onset
Exclusion
- Patients without informed consent. Patients discharged with a diagnosis different from stroke or TIA after diagnostic evaluation.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
1102 Patients enrolled
Trial Details
Trial ID
NCT00878813
Start Date
March 1 2009
End Date
October 1 2011
Last Update
November 10 2011
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Abteilung für Neurologie Charité - Campus Benjamin Franklin
Berlin, Germany
2
Goethe University
Frankfurt am Main, Germany
3
Neurologische Klinik, Universitätsspital Basel
Basel, Switzerland, 4031
4
University Clinic for Neurology, Bern University Hospital
Bern, Switzerland, 3010